GLENZOCIMAB
UNII 58D9BCH9O0

Substance Identification & Data

This profile provides standardized clinical and technical data for Glenzocimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 58D9BCH9O0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2101829-58-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

58D9BCH9O0

CAS Registry Number

2101829-58-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GLENZOCIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166827

National Cancer Institute reference terminology for clinical and research data.

INN ID

10956

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-152

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Glenzocimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GLENZOCIMAB

Common Names & Synonyms

GLENZOCIMAB [INN]

GLENZOCIMAB [USAN]

GLENZOCIMAB [WHO-DD]

IMMUNOGLOBULIN FAB G1-KAPPA, ANTI-(HOMO SAPIENS GP6 (GLYCOPROTEIN VI PLATELET, GLYCOPROTEIN VI (PLATELET), GPVI, PLATELET GLYCOPROTEIN VI)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN VH-CH1 HUMANIZED (1-227) (VH (HOMO SAPIENS IGHV1-46*01 (92.9%) -(IGHD) -IGHJ4*01 (93.3%)) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*01, G1M17 (CH1 K120 (217) (121-218), HINGE 1-9 (219-227)) (121-227)), (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (80.0%) -IGKJ1*01 (100%)) (11.3.9) (1'-111') -1-MER (112') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219'))

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATETET GLYCOPROTEIN VI) FAB FRAGMENT (HUMANIZED MONOCLONAL ACT017 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL ACT017 .KAPPA.-CHAIN

Technical Codes

ACT017

ACT-017

External Clinical & Regulatory Resources

Previous UNII58D606078H

Next UNII58DNV0B13N